Jed A. Latkin

2018

In 2018, Jed A. Latkin earned a total compensation of $639.9K as Chief Executive Officer, Chief Operating Officer and Chief Financial Officer at Navidea Biopharmaceuticals, a 21% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$271,875
Salary$362,500
Other$5,500
Total$639,875

Latkin received $362.5K in salary, accounting for 57% of the total pay in 2018.

Latkin also received $271.9K in non-equity incentive plan and $5.5K in other compensation.

Rankings

In 2018, Jed A. Latkin's compensation ranked 11,041st out of 14,244 executives tracked by ExecPay. In other words, Latkin earned more than 22.5% of executives.

ClassificationRankingPercentile
All
11,041
out of 14,244
23rd
Division
Manufacturing
4,450
out of 5,765
23rd
Major group
Chemicals And Allied Products
1,689
out of 2,128
21st
Industry group
Drugs
1,433
out of 1,817
21st
Industry
In Vitro and In Vivo Diagnostic Substances
52
out of 72
28th
Source: SEC filing on June 28, 2019.

Latkin's colleagues

We found four more compensation records of executives who worked with Jed A. Latkin at Navidea Biopharmaceuticals in 2018.

2018

Michael Goldberg

Navidea Biopharmaceuticals

Chief Executive Officer

2018

Joel Kaufman

Navidea Biopharmaceuticals

Chief Business Officer

2018

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

2018

Michael Rosol

Navidea Biopharmaceuticals

Chief Medical Officer

News

You may also like